John Wrangle to Biomarkers, Tumor
This is a "connection" page, showing publications John Wrangle has written about Biomarkers, Tumor.
Connection Strength
0.378
-
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum. Clin Cancer Res. 2017 04 15; 23(8):1998-2005.
Score: 0.105
-
Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin Cancer Res. 2014 Apr 01; 20(7):1856-64.
Score: 0.087
-
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clin Chim Acta. 2013 Oct 21; 425:169-75.
Score: 0.084
-
Chemoprevention of squamous cell carcinoma of the head and neck. Curr Opin Oncol. 2007 May; 19(3):180-7.
Score: 0.054
-
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma. Clin Cancer Res. 2018 11 01; 24(21):5250-5260.
Score: 0.030
-
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 2011 Dec; 1(7):598-607.
Score: 0.019